AI Verdict
RARE has stronger fundamentals based on our AI analysis.
RAVE vs RARE Fundamental Comparison
| Metric | RAVE | RARE |
|---|---|---|
| Revenue | $6.3M | $673.0M |
| Net Income | $1.3M | $-575.0M |
| Net Margin | 20.5% | -85.4% |
| ROE | 8.3% | N/A |
| ROA | 7.3% | -37.5% |
| Current Ratio | 8.50x | 2.48x |
| Debt/Equity | 0.00x | N/A |
| EPS | $0.09 | $-5.83 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RAVE vs RARE: Frequently Asked Questions
Is RAVE or RARE a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RARE has stronger fundamentals. RAVE is rated SELL (60% confidence) while RARE is rated SELL (72% confidence). This is not investment advice.
How does RAVE compare to RARE fundamentally?
RAVE RESTAURANT GROUP, INC. has ROE of 8.3% vs Ultragenyx Pharmaceutical Inc.'s N/A. Net margins are 20.5% vs -85.4% respectively.
Which stock pays higher dividends, RAVE or RARE?
RAVE has a dividend yield of N/A or no dividend while RARE has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RAVE or RARE for long term?
For long-term investing, consider that RAVE has SELL rating with 60% confidence, while RARE has SELL rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RAVE vs RARE?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RAVE vs RARE, the AI consensus favors RARE based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.